Autotransfusion Devices Market Analysis: Major Players, Lucrative Segments And Top Geographies
28 Jul, 2023
The global autotransfusion devices market size is expected to grow from $1.11 billion in 2022 to $1.17 billion in 2023 at a compound annual growth rate (CAGR) of 5.65%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global autotransfusion devices market size is expected to reach $1.47 billion in 2027 at a CAGR of 5.81%.
Global Autotransfusion Devices Market Key Driver
The rising number of surgical procedures is likely to propel the autotransfusion devices market forward. Surgical procedures are medical operations that include making an incision or damaging tissues in the body in order to remove, repair, or modify a body part. In surgical operations, autotransfusion devices can be utilized to reduce blood loss and enhance patient outcomes.
Get a sample of the global autotransfusion devices market reportGlobal Autotransfusion Devices Market Segments
The global autotransfusion devices market is segmented:
1) By Product Type: Autotransfusion Systems, Consumables And Accessories
2) By Application: Cardiovascular Surgeries, Orthopedic Surgeries, Neurological Surgeries, Obstetrics And Gynecology Surgeries, Other Applications
3) By End-Use: Hospitals, Specialty Clinics, Other End Users
4) By Geography: The regions covered in the autotransfusion devices market report are Asia-Pacific, Western Europe, Eastern Europe,North America, South America, Middle East, and Africa. Among these regions, North America accounts for the largest share in the global autotransfusion devices market.
Major Autotransfusion Devices Industry Players
Becton Dickinson And Company, Medtronic PLC, LivaNova PLC, Haemonetics Corporation, Fresenius SE & Co KGaA, TERUMO BCT, Asahi Kasei Medical Co Ltd., Miltenyi Biotec, B. Braun Melsungen AG, GE Healthcare, Cerus Corporation, Fresenius Kabi AG, Stryker Corporation, Atrium Medical Technologies, Brightwake Ltd, Getinge AB
Get the full global autotransfusion devices market report
Autotransfusion Devices Market Overview
Autotransfusion devices refer to tools used to collect and reinfuse a patient's blood during a medical procedure, instead of using donated blood. This process is also known as autologous blood transfusion and can help reduce the need for allogenic (separate-donor) blood transfusions. Autotransfusion devices are commonly used in trauma patients in the emergency department and during surgeries.
Autotransfusion Devices Global Market Report 2023 provides data on the global autotransfusion devices market such as market size, growth forecasts, segments and geographies, competitive landscape including leading competitors’ revenues, profiles and market shares. The autotransfusion devices market report identifies opportunities and strategies based on market trends and leading competitors’ approaches.